ARCHIVED      PDF Version     To Publications Page     To Home Page

Title:

National Prescription Drug Threat Assessment 2009

Publication Date: April 2009

Document ID: 2009-L0487-001

Cover image for National Prescription Drug Threat Assessment 2009.

Archived on: January 1, 2012. This document may contain dated information. It remains available to provide access to historical materials.

This assessment focuses primarily on domestic diversion of controlled prescription drugs (CPDs). It examines current nonmedical use of prescription-type psychotherapeutic drugs (opioid pain relievers, tranquilizers, sedatives, or stimulants) and discusses their distribution, the societal impact of CPD diversion and abuse, and Prescription Drug Monitoring Programs (PDMPs) that have been established legislatively in many states to stem CPD diversion and abuse. This assessment also examines regional deviations from national trends.

Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.


Contents

Executive Summary

Scope and Methodology
   Information Sources
   Collection Impediments
   Collection Methods
   Range of Data
   Data Terminology
   Database Variances

Background

Overview

Foreword

Legitimate Distribution of CPDs

Diversion of CPDs

Combating Diversion

Illicit Finance

Abuse

 

Intelligence Gaps

Predictive Estimates

Regional Deviations From National Trends
   Florida/Caribbean Region
   Great Lakes Region
   Mid-Atlantic Region
   New England Region
   New York/New Jersey Region
   Pacific Region
   Southeast Region
   Southwest Region
   West Central Region

Appendix A. NDTS Comparative Data
   Greatest Drug Threat
   Availability
   Drugs Associated With Violent Crime
   Drugs Associated With Property Crime

Appendix B. Controlled Prescription Drug Prices Collected in 2008

Sources


List of Figures

Figure 1. Prescription Opioid Analgesic Deaths Nationwide, 2001-2005
Figure 2. Past Month Nonmedical Use of Psychotherapeutics by Individuals 12 or Older, by Percentage, Nationwide, 2003-2007
Figure 3. Cumulative Distribution of Opioids, Methylphenidate, and Amphetamine, in Grams, per 100,000 Population, 2003-2007
Figure 4. Estimated Number of Total Analyzed Controlled Prescription Drug Items, 2003-2007
Figure 5. Internet Sites Advertising or Offering to Sell Controlled Prescription Drugs, 2004-2008
Figure 6. Percentage of Law Enforcement Agencies Reporting High Availability of Pharmaceuticals, by OCDETF Region, 2004-2008
Figure 7. Percentage of Law Enforcement Agencies Reporting an Association Between Diverted Pharmaceuticals and Crime, 2004-2008
Figure 8. Percentage of Law Enforcement Agencies Reporting Street Gang Involvement in Pharmaceutical Distribution, by OCDETF Region, 2004-2008
Figure 9. Percentage of Law Enforcement Agencies Reporting OMG Involvement in Pharmaceutical Distribution, by OCDETF Region, 2004-2008
Figure 10. Status of Prescription Drug Monitoring Programs as of January 1, 2009
Figure 11. Aggregate Production Quotas for Selected Schedule II Controlled Prescription Drugs, in Kilograms, 2004-2008
Figure 12. Percentage of Past Month Nonmedical Use of Psychotherapeutics, by Age, 2003-2007
Figure 13. Specific Drug Used When Initiating Illicit Drug Use Among Past Year Initiates of Illicit Drugs, Aged 12 or Older, 2007
Figure 14. Past Year Initiates for Specific Illicit Drugs Among Persons Aged 12 or Older, in Thousands, 2007
Figure 15. Past Month Nonmedical Use of Psychotherapeutics by Individuals 12 and Older, in Percentages, 2003-2007
Figure 16. Percentage of Teenagers Who Used a Prescription Pain Reliever or Stimulant Not Prescribed for Them, 2004-2008
Figure 17. Percentage of Teenagers With Friends or Classmates Who Abuse Prescription Drugs, 2004-2008
Figure 18. Past Month Use of Psychotherapeutics Among 12- to 17-Year-Olds, in Percentages, 2003-2007
Figure 19. Unintentional Prescription Opioid Analgesic, Cocaine, and Heroin Deaths Nationwide, 2001-2005
Figure 20. Organized Crime Drug Enforcement Task Force Regions.
Figure 21. Percentage of Law Enforcement Agencies Reporting Greatest Drug Threat, by Drug, Nationwide, 2004-2008
Figure 22. Percentage of Law Enforcement Agencies Reporting High Availability, by Drug, Nationwide, 2004-2008
Figure 23. Percentage of Law Enforcement Agencies Reporting Association Between Drug Type and Violent Crime, Nationwide, 2004-2008
Figure 24. Percentage of Law Enforcement Agencies Reporting Association Between Drug Type and Property Crime, Nationwide, 2004-2008

List of Tables

Table 1. Prescriptions Written for Generic or Brand Name Opioid Pain Relievers, Methylphenidate, and Amphetamine, in Thousands, 2003-2007
Table 2. Controlled Prescription Drug Seizures Reported to the National Seizure System, by Measurement Provided, 2003-2008
Table 3. Schedule II-V Controlled Prescription Drugs Reported Stolen or Lost in Transit Nationwide in Milliliters and Quantities, 2003-2007
Table 4. Percentage of Law Enforcement Agencies Reporting High Levels of Diversion/Illicit Use of Pharmaceuticals, 2006-2008
Table 5. Trends in Annual Prevalence of Nonmedical Use of Prescription Drugs in Grades 8, 10, and 12, by Percentage, 2004-2008
Table 6. Emergency Department Visits for Nonmedical Use of Selected Controlled Prescription Drugs and Percent of Change, 2004-2006

List of Tables in Appendix B

Table B1. Controlled Prescription Drug Prices Collected in 2008


Addresses

National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov
 

Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue NW
Washington, DC 20530-2000

Tel. (202) 432-4040
FAX (202) 514-4252

Web Addresses

ADNET:  http://ndicosa.adnet.sgov.gov/index.htm
DOJ:  http://www.usdoj.gov/archive/ndic/
LEO:  https://www.leo.gov/http://leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS:  ndic.riss.net


Questions and comments may be directed to Special Projects Unit, National Threat Analysis Branch through NDIC.Contacts@usdoj.gov.


To Top     To Contents      To Next Page

To Publications Page      To Home Page

UNCLASSIFIED


End of page.